Supreme Court asked to restore access to mail-order abortion pill
Danco Laboratories has asked the Supreme Court to overturn a lower court ruling that blocks the mail-order distribution of mifepristone, a medication used in abortions. The company argues the ruling creates confusion and disrupts access for patients and providers nationwide. The lower court's decision temporarily reinstates restrictions on the drug, reversing FDA guidelines that had eased access.
- ▪Danco Laboratories filed an emergency application with the Supreme Court to lift a 5th Circuit Court ruling restricting mail-order access to mifepristone.
- ▪The 5th Circuit's ruling blocks 2023 FDA guidelines that had expanded access to the abortion pill, citing a safety review initiated under the Trump administration.
- ▪Louisiana, which brought the legal challenge, is being opposed by Danco, which argues the state lacks standing to sue over FDA drug approval decisions.
Opening excerpt (first ~120 words) tap to expand
ABC NewsLiveVideoShowsGood Morning AmericaShopGMAInterest Successfully AddedWe'll notify you here with news aboutTurn on desktop notifications for breaking stories about interest? OffOnStream onSupreme Court asked to restore access to mail-order abortion pill mifepristoneAn appeals court on Friday barred the telehealth distribution of the pill.ByPeter Charalambous and Devin DwyerMay 2, 2026, 4:00 PM1:16In this April 13, 2023, file photo, packages of Mifepristone tablets are displayed at a family planning clinic, in Rockville, Md.Anna Moneymaker/Getty Images, FILEA pharmaceutical company that produces mifepristone asked the Supreme Court on Saturday to lift a lower court's ruling prohibiting health providers from dispensing the abortion pill by mail.In an emergency application filed…
Excerpt limited to ~120 words for fair-use compliance. The full article is at ABC News: Top Stories.
Discussion
0 commentsMore from ABC News: Top Stories
